Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.
Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...
Eli Lilly (LLY) announced that the Medicines and Healthcare products Regulatory Agency, or MHRA, has granted marketing authorization for ...
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
Spirit Airlines (SAVE) extends its debt refinancing deadline with the US Bank National Association, sending the stock soaring ...
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
The Smithsonian Institution has received $40m from the Lilly Endowment for its upcoming celebrations of the 250th anniversary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback